Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Small Molecule Drug Discovery Market?

The market size for small molecule drug discovery has experienced robust growth in recent periods. It is predicted to expand from a value of $62.44 billion in 2024 to $67.94 billion in 2025, with a compound annual growth rate (CAGR) of 8.8%. The historical growth has been driven by factors such as drug repurposing efforts, the automation of drug discovery, a boost in funding for research and development, regulatory encouragement for drug creation, and progress in high-throughput screening.

There is an anticipated swift expansion in the small molecule drug discovery market in the coming years, with the market predicted to surge to $104.6 billion by 2029, boasting a compound annual growth rate (CAGR) of 11.4%. Several factors are expected to fuel this growth during the forecast period, including the arrival of new therapeutic targets, a rise in patient-centric drug discovery, the inclusion of drug-device combination products, the use of real-world evidence, the incorporation of pharmacogenomics, and widespread health challenges. Key trends predicted in this time frame include advancements in fragment-based drug discovery, the use of artificial intelligence in drug discovery, focus on rna-targeted therapeutics, increased partnerships and collaborations, innovative approaches in drug delivery, and the growing uptake of organoids and 3d cell culture models.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

Which Factor Is Shaping The Future Of The Small Molecule Drug Discovery Market?

The increase in chronic disease prevalence is projected to spur the expansion of the small molecule drug discovery market. Chronic diseases implicate conditions lasting a year or more, impeding daily activities, requiring ongoing medical attention, or both. Chronic ailments such as HIV, cancer, infections, heart disease, and renal disease can be treated with small-molecule drugs, which are typically more affordable for such patients. Consequently, the surge in chronic diseases will likely stimulate the small molecule drug discovery market. For example, the National Institutes of Health (NIH), a US-based biomedical research agency, reported that in 2023, the population aged 50 and above with at least one chronic disease is anticipated to escalate by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050 in the U.S. Furthermore, the multimorbid population will see a 91.16% increase from 7.8304 million in 2020 to 14.968 million in 2050. Hence, the escalation in chronic diseases is propelling the small molecule drug discovery market’s growth.

What Is The Segment-Wise Breakdown Of The Small Molecule Drug Discovery Market?

The small molecule drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule Drugs, Biologic Drugs

2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others

3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others

4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization

5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others

Subsegments:

1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs

2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies

Which Trends Are Redefining The Future Landscape Of The Small Molecule Drug Discovery Industry?

One of the prominent trends in the small molecule drug discovery market is advancements in technology. Expansion strategies for major companies in this market often involve creating novel products. To exemplify, Dotmatics, a digital science platform from the US, introduced its Small Molecule Drug Discovery Solution in January 2023. This unique solution provides an interwoven scientific R&D platform, complete with optimized workflows and extensive data management abilities. This innovative product aims to decrease operational shortcomings, and fast track the transition of data to informed decisions.

Which Companies Hold The Largest Market Share In The Small Molecule Drug Discovery Sector?

Major companies operating in the small molecule drug discovery market include Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Clinuvel Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Pharmacosmos, Allarity Therapeutics, Xellia Pharmaceuticals, Cyteir Therapeutics, BigHat Biosciences

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

How Does Regional Performance Compare Across The Small Molecule Drug Discovery Industry?

North America was the largest region in the small molecule drug discovery market in 2024. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9834&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model